414
Views
59
CrossRef citations to date
0
Altmetric
CANCER EPIDEMIOLOGY

Cancer Incidence and Survival in Adolescents and Young Adults in France, 2000–2008

, , , , , , , , , , , , , , , & show all
Pages 291-306 | Received 08 Nov 2012, Accepted 22 Dec 2012, Published online: 30 Jan 2013
 

Abstract

This study aimed to describe cancer incidence (2000–2008) and survival (2000–2004) in France in adolescents and young adults (AYA). All cases of cancer diagnosed in 15–24 years, recorded by all French population-based registries (14% of the French population), over the 2000–2008 period, were included. Incidence change over time was described with the conventional annual percentage change (cAPC). The survival of cases diagnosed (2000–2004) was estimated using Kaplan–Meier method. A total of 1022 in adolescents and 1396 in young adults were diagnosed. Overall incidence rates were 219.4/106 in 15–19 year olds and 293.1/106 in 20–24 year olds. The most frequently diagnosed cancers in male AYA were malignant gonadal germ-cell tumors and Hodgkin's disease, and were melanoma, thyroid carcinoma, and Hodgkin's disease in females. The age-standardized rates appeared stable over time in AYA, with a cAPC of +2.0% (P = 0.68). The 5-year overall survival for all cancers was different between genders and age groups, with 78.8% (95%CI: 75.6–82.0) for males and 85.2% (95%CI: 82.2–88.1) for females (P = 0.01), and 78.5% (95%CI: 75.0–82.1) in 15–19 year olds and 84.3% (95% CI: 81.6–87.0) in 20–24 year olds (P = 0.02). Noteworthy, the frequency and the distribution of tumor types in AYA are unique and different from the observed at any other age group. Survival in French AYA has improved over time. Epidemiological data might reflect major trends in the risk factors and preventive interventions. Thus, further research into etiology of cancers affecting AYA should become key priorities for cancer control among AYA.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.